33548 Federal Register / Vol. 65, No. 101 / Wednesday, May 24, 2000 / Notices

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Lynn S. Fox, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.federalreserve.gov for an

electronic announcement that not only

lists applications, but also indicates

procedural and other information about

the meeting.

Dated: May 19, 2000.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 00–13125 Filed 5–22–00; 8:45 am]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00059]

Prevention Epicenters Program; Notice

of Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2000

funds for a cooperative agreement

program for Prevention Epicenters. CDC

is committed to achieving the health

promotion and disease prevention

objectives of ‘‘Healthy People 2010’’, a

national activity to reduce morbidity

and mortality and improve the quality

of life. This announcement is related to

the focus areas of Access to Quality

Health Services and Immunization and

Infectious Diseases. For the conference

copy of ‘‘Healthy People 2010’’, visit the

internet site http://www.health.gov/

healthypeople.

The purpose of the program is to

assist healthcare organizations and

institutions to support established

Prevention Epicenters or to develop new

Prevention Epicenters as part of the

CDC’s Prevention Epicenters (PE)

program. The PE program is designed to

develop, implement, and evaluate the

effectiveness of epidemiologically-based

strategies to improve healthcare quality

and assure patient safety by preventing

adverse events associated with

healthcare including, but not limited to,

healthcare-associated infections, and

antimicrobial resistant infections. (See

Attachment II Background for more

information.)

The goals of the PE program are to: (1)

Support activities which lead to

improvements in information system

capacity to monitor healthcare system

performance and healthcare outcomes.

Such activities should expand the use of

information technology to acquire,

integrate, process, analyze, and report

information, and use information

technology to develop and implement

innovative interventions to prevent

infections and other adverse health

events; (2) be a national resource for

building epidemiologic capacity in

healthcare outcomes research. PE

program activities should extend the

capacity of healthcare epidemiology and

infection control programs to address

patient safety, cost effectiveness,

prevention effectiveness, healthcare

outcomes monitoring, and performance

measurement; and (3) support activities

which develop an infrastructure to

address the above goals in the broadest

spectrum of healthcare delivery settings,

including acute care hospitals, longterm care facilities, rehabilitation

programs, dialysis centers, home

healthcare programs, ambulatory care

programs, and others.

Specific objectives for the pilot and

developmental phases of the project will

include identifying (1) appropriate

populations, (2) outcome measures, (3)

data collection methods, and (4)

interventions to be instituted in year 2

of the project.

Each Prevention Epicenter will be

established within a healthcare network

or system, integrated healthcare delivery

system (IDS), or managed care

organization (MCO) which serves a large

and diverse group of people. Through

the network, system, or organization,

the Prevention Epicenter should have

access to patients in a variety of

healthcare settings (e.g., long-term care,

rehabilitation, home health care,

ambulatory care, dialysis centers, etc.).

The population served by the

components of the system should be

definable based on the network’s,

system’s, or organization’s knowledge of

historical patterns of use of services by

patients and/or the demographics of

enrollment in managed healthcare plans

served by the network, system, or

organization. Prevention Epicenters will

work together as part of a national

multi-center collaborative research and

demonstration program in the areas of

patient safety and healthcare outcomes

research.

B. Eligible Applicants

Applications may be submitted by

public and private nonprofit

organizations and by governments and

their agencies; that is, universities,

colleges, research institutions, hospitals,

other public and private nonprofit

organizations, State and local

governments or their bona fide agents,

and federally recognized Indian tribal

governments, Indian tribes, or Indian

tribal organizations.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $2,000,000 is available

in FY 2000 to fund approximately 10

awards (up to eight competing

continuations and one or two new

Prevention Epicenters). It is expected

that the average award for the existing

Prevention Epicenters will range from

approximately $100,000 to $450,000,

depending on the activities funded per

site, and the average award for new

Prevention Epicenters will range from

approximately $75,000 to $250,000.

More funds are available for existing

Prevention Epicenters because they are

mature, fully-functional programs and

new Prevention Epicenters might need

up to 12 to 24 months to become fullyfunctional and able to participate in all

activities.

It is expected that the awards will

begin on or about September 30, 2000,

and will be made for a 12-month budget

period within a project period of up to

5 years. The funding estimate may

change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

Funding Preferences

1. Although applications for new

programs are encouraged, funding

preference will be given to the

competing continuation applications

over applications for programs not

already receiving support under the

existing Prevention Epicenter program.

The current awardees already have the

infrastructure needed to continue the

Prevention Epicenter program.

2. To achieve appropriate

representation in the Prevention

Epicenters program, funding preference

may be given to approved applications

that would enhance the racial, ethnic,

Federal Register / Vol. 65, No. 101 / Wednesday, May 24, 2000 / Notices 33549

socioeconomic, and/or geographic

diversity of the program.

D. Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under 1. (Recipient Activities), and CDC

will be responsible for the activities

listed under 2. (CDC Activities).

1. Recipient Activities

a. Establish and/or operate a

Prevention Epicenter that is consistent

with the purposes of the program.

b. Establish collaborative and

cooperative relationships with other

public and private organizations that

have an interest in outcomes research,

disease management, prevention

effectiveness, prevention of adverse

health outcomes, patient safety, and

healthcare quality in order to maximize

access to, and participation of, relevant

study populations.

(1) Collaborate with other Prevention

Epicenters to establish a PE program

advisory committee and participate in

the project planning activities.

(2) Collaborate with other Prevention

Epicenters on one or two core program

activities. Core program activities are

defined as activities intended to become

multicenter collaborative projects

addressing the three goals of the PE

program.

(3) Propose and conduct one or more

investigator-initiated projects.

Investigator initiated projects may

address issues of local interest or

concern that are in keeping with the

goals of the PE program. In addition to

focusing on defined patient populations,

investigator-initiated projects may

address issues that include, but are not

limited to: healthcare personnel

behavior modification, healthcare

personnel safety, laboratory-based

assessment and interventions, and the

monitoring and control of antimicrobial

resistance.

(4) Manage, analyze, and interpret

data, and publish and disseminate

important medical and public health

information stemming from Prevention

Epicenter projects in collaboration with

other PE program sites.

(5) Monitor and evaluate scientific

and operational accomplishments and

progress in achieving the purpose of this

program.

2. CDC Activities

a. Collaborate, as appropriate, with

the recipient in all stages of the

program, and provide programmatic and

technical assistance.

b. As requested, participate in data

collection, analysis, and interpretation

of data from Prevention Epicenter

projects. Provide scientific

collaboration.

c. As requested, participate in the

dissemination of findings and

information stemming from Prevention

Epicenter projects.

d. Participate in improving program

performance through consultation based

on information and activities of other

projects.

e. As requested, perform laboratory

evaluation of specimens or isolates (e.g.,

molecular epidemiologic studies,

evaluation of diagnostic tools) obtained

in Prevention Epicenter projects.

f. As requested, facilitate

communication of data and results

among Prevention Epicenters.

g. Assist in the development of

research protocols for IRB review by all

cooperating institutions participating in

the research project.

The CDC IRB will review and approve

the protocol initially and on at least an

annual basis until the research project is

completed.

E. Application Content

Use the information in the Program

Requirements, Other Requirements and

Evaluation Criteria sections to develop

the application content. Your

application will be evaluated on the

criteria listed, so it is important to

follow them in laying out your program

plan. The narrative should not be more

than 25 single-spaced pages printed on

one side, with one inch margins and

unreduced font. Applications should

follow the PHS 398 (rev. 4/98)

application and Errata sheet, and should

include the following information.

1. Submission of an application for at

least two but no more than three project

activities in total. Each activity

proposal, including the proposed

multicenter collaborative projects (core

program activities), and investigatorinitiated activities, should be clearly

identified in a distinct portion of the

Operational Plan. Although the

activities proposed may address distinct

issues and needs, they may be

implemented in an integrated manner

such that staff members work on more

than one activity, or supplies and

equipment are shared.

Note: Approximately 50–80 percent of

resources will go to the core, multicenter

collaborative activities.

2. Provide a line-item budget and

narrative justification for all requested

costs, and separate line-item budgets for

each proposal submitted to conduct core

program activities and investigatorinitiated activities. Budgets should be

consistent with the purpose, objectives

and research activities, and include:

a. Line-item breakdown and

justification for all personnel, i.e., name,

position title, annual salary, percentage

of time and effort, and amount

requested.

b. For each contract: (1) Name of

proposed contractor, (2) breakdown and

justification for estimated costs, (3)

description and scope of activities to be

performed by contractor, (4) period of

performance, (5) method of contractor

selection (e.g., sole-source or

competitive solicitation) and (6) method

of accountability.

c. A brief five-year budget projection

should be submitted that clearly

separates and distinguishes direct from

indirect costs.

d. A description of any financial and

in-kind contributions from nonfederal

sources.

Additionally, for each proposed

activity (core and investigator-initiated)

include a one-page, single-spaced, typed

abstract. The heading should include

the title of the cooperative agreement,

project title, organization, name and

address, project director, and telephone

number. This abstract should include a

workplan identifying activities to be

developed, activities to be completed,

and a time-line for completion of these

activities.

F. Submission and Deadline

Letter of Intent

In order to enable CDC to determine

the level of interest in the program

announcement, a non-binding letter-ofintent to apply is requested from

potential applicants. Your letter-ofintent should identify program

announcement number 00059, and

include the following information: (1)

Name and address of institution, and (2)

name, address, telephone number, email address, and fax number of contact

person. On or before June 9, 2000,

submit the letter-of-intent (original and

two copies) to the Grants Management

Specialist identified in the ‘‘Where to

Obtain Additional Information’’ section

of this announcement.

Application

Submit the original and five copies of

PHS 398 (OMB Number 0925–0001) and

adhere to the instructions on the Errata

Instruction Sheet for PHS 398). Forms

are in the application kit.

On or before July 11, 2000, submit the

application to the Grants Management

Specialist identified in the ‘‘Where to

Obtain Additional Information Section

of this announcement.

Deadline: Applications shall be

considered as meeting the deadline if

they are either:

33550 Federal Register / Vol. 65, No. 101 / Wednesday, May 24, 2000 / Notices

(a) Received on or before the deadline

date; or

(b) Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.)

Late Applications: Applications

which do not meet the criteria in (a) or

(b) above are considered late

applications, will not be considered,

and will be returned to the applicant.

G. Evaluation Criteria

Each competing continuation

Prevention Epicenter and new

application will be evaluated

individually against the following

criteria by an independent review group

appointed by CDC.

Competing Continuation PE Centers

1. Establishment of Prevention

Epicenter (30 points)

a. Productivity

Extent to which the competing

continuation Center has used program

resources to successfully conduct

research and demonstration projects as

evidenced by submission of abstracts to

national scientific meetings;

presentations at local, regional and

national conferences, meetings, and

other settings for information exchange;

and publications in scientific journals,

lay media, public or healthcare provider

information and educational sources.

b. Institutionalization

Extent to which the Prevention

Epicenter has been established within

the home institution and network/

system/organization as evidenced by

collaboration with other departments,

institutions, and components of the

network/system/organization; support

from officials and representatives of the

home institution and networks;

recognition in internal publications and

documents; and collaboration as a

Prevention Epicenter with entities

outside the network/system/

organization.

2. Existing Capacity (30 points)

Description of existing capacity to

conduct outcomes research and

prevention effectiveness research in the

areas of healthcare-associated infections

and other adverse events associated

with healthcare.

a. Description of applicant’s

experience and documentation of

accomplishments in conducting

healthcare outcomes research and

quality improvement activities,

including projects and studies

involving: database integration;

outcomes data acquisition, validation,

and analysis; cost-and resourceeffectiveness and cost-utility

assessment; performance measurement

and performance improvement; quality

of care assessment and intervention

clinical and laboratory process and

outcomes assessment; and provider and

patient behavior change studies and

interventions. (A list of relevant papers

and abstracts should be included in an

appendix.)

b. Description of applicant’s

experience and documentation of

accomplishments in conducting

surveillance, applied epidemiologic

research, applied laboratory research,

and prevention research in the areas of

healthcare-associated infections and

other adverse events (e.g., antimicrobial

drug resistant infections, device-related

infections, medication errors, etc.) A list

of relevant papers and abstracts should

be included in an appendix.

c. Demonstration of applicant’s ability

to develop and maintain strong

cooperative relationships with medical,

public health, laboratory, academic, and

community organizations that are either

public or private, local or regional.

Evidence of applicant’s ability to solicit

and secure programmatic collaboration,

and financial and technical support

from such organizations.

d. Demonstration of support from

non-applicant participating agencies,

institutions, organizations, laboratories,

individuals, consultants, etc.,

mentioned in the operational plan.

Applicant should provide (in an

appendix) letters of support which

clearly indicate each collaborator’s

willingness to participate in studies and

other activities with the Prevention

Epicenter. The letters should clearly

define the roles of these collaborations.

e. Demonstration of applicant’s ability

to participate in multicenter research

and demonstration studies.

3. Operational Plan (35 points)

a. The extent to which the applicant’s

plan for establishing, operating, and

maintaining the Prevention Epicenter

clearly describes the proposed activities

and clearly identifies the roles and

responsibilities of all participating

individuals, agencies, organizations,

and institutions.

b. The extent to which the applicant

describes plans for collaboration with

other PE program sites in the

establishment and operation of the PE

program and individual Prevention

Epicenter projects, including

participation in advisory committee and

subcommittee activities, as well as

project design/development (e.g.,

protocols), management and analysis of

data, and synthesis and dissemination

of findings.

c. Description and quality of

applicant’s partnerships with necessary

and appropriate individuals,

departments, agencies and organizations

for establishing and operating the

proposed Prevention Epicenter projects.

d. Consistency of the proposed

projects with regard to Prevention

Epicenter program goals.

e. Description of the operational plan

for conducting core multicenter

collaborative projects, including the

extent to which: (1) The project is

consistent with one or more of the

stated goals of the PE program, (2) the

objectives of the proposed project are

specific, measurable, and time-phased;

(3) the plan clearly describes applicant’s

technical approach/methods for

conducting the proposed project(s); and

(4) the plan is adequate to accomplish

the stated objectives.

f. Description of the operational plan

for conducting one or two investigatorinitiated projects, including the extent

to which: (1) The project is consistent

with one or more of the stated goals of

the PE program, (2) the objectives of the

proposed project are specific,

measurable, and time-phased; (3) the

plan clearly describes applicant’s

technical approach/methods for

conducting the proposed project(s); and

(4) the plan is adequate to accomplish

the stated objectives.

g. Identification of applicant’s key

professional personnel to be assigned to

the Prevention Epicenter and to specific

projects as well as key professional

personnel from other participating or

collaborating institutions, agencies,

organizations outside of the applicant’s

agency that will be assigned to PE

activities (provide curriculum vitae for

each in an appendix). Clear

identification of applicants’ respective

roles in the management and operation

of the Prevention Epicenter and in

individual projects. Descriptions of

participants’ experience in conducting

work similar to that proposed in this

announcement.

h. Description of all support staff and

services to be assigned to the Prevention

Epicenter.

i. The degree to which the applicant

has met the CDC Policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed research. This includes (1) the

proposed plan for the inclusion of both

sexes and racial and ethnic minority

Federal Register / Vol. 65, No. 101 / Wednesday, May 24, 2000 / Notices 33551

populations for appropriate

representation, (2) the proposed

justification when representation is

limited or absent, (3) a statement as to

whether the design of the study is

adequate to measure differences when

warranted and (4) a statement as to

whether the plans for recruitment and

outreach for study participants include

the process of establishing partnerships

with community(ies) and recognition of

mutual benefits.

4. Evaluation (5 points)

a. Quality of plan for monitoring and

evaluating scientific and operational

accomplishments of the Prevention

Epicenter and of individual Center

projects.

b. Quality of plan for monitoring and

evaluating progress in achieving the

purpose and overall goals of this

cooperative agreement program.

5. Budget (not scored)

Extent to which the line-item budget

is detailed, clearly justified, and

consistent with the purpose and

objectives of this program.

6. Human Subjects (not scored)

Does the application adequately

address the requirements of Title 45

CFR part 46 for the protection of human

subjects?

New Applicants

1. Understanding the objectives of the

PE program (5 points)

a. Demonstration of a clear

understanding of the background and

objectives of this cooperative agreement

program.

b. Demonstration of a clear

understanding of the requirements,

responsibilities, problems, constraints,

and complexities that may be

encountered in establishing and

operating the Prevention Epicenter.

c. Demonstration of a clear

understanding of the roles and

responsibilities of participation in the

PE program.

2. Description of the healthcare network

or system, IDS, or MCO in which the

Prevention Epicenter is situated and the

population served by the network/

system/organization (10 points)

a. Clear definition of the components

of the network/system/organization,

their relationship to the Prevention

Epicenter, the geographic area and the

population base in which the

Prevention Epicenter will operate.

b. Clear description of the populations

served, the health care services

provided, and the healthcare settings

within which defined population(s)

receive care, as they relate to the

proposed activities of the PE program.

c. Clear description of the

management information systems of the

network/system/organization, with

emphasis on the level of integration of

patient level electronic data sources

within and between facilities, including

electronic data bases containing clinical,

administrative, laboratory, pharmacy,

and other data. Description of the

availability and accessibility of such

data for outcomes-type research.

d. Extent to which the population

base is diverse demographically.

3. Description of existing capacity to

conduct outcomes research and

prevention effectiveness research in the

areas of healthcare-associated infections

and other adverse events associated

with healthcare (35 points)

a. Description of applicant’s

experience and documentation of

accomplishments in conducting

healthcare outcomes research and

quality improvement activities,

including projects and studies

involving: database integration;

outcomes data acquisition, validation,

and analysis; cost- and resourceeffectiveness and cost-utility

assessment; performance measurement

and performance improvement; quality

of care assessment and intervention

clinical and laboratory process and

outcomes assessment; and provider and

patient behavior change studies and

interventions. (A list of relevant papers

and abstracts should be included in an

appendix.)

b. Description of applicant’s

experience and documentation of

accomplishments in conducting

surveillance, applied epidemiologic

research, applied laboratory research,

and prevention research in the areas of

healthcare-associated infections and

other adverse events (e.g., antimicrobial

drug resistant infections, device-related

infections, medication errors, etc.) A list

of relevant papers and abstracts should

be included in an appendix.

c. Demonstration of applicant’s ability

to develop and maintain strong

cooperative relationships with medical,

public health, laboratory, academic, and

community organizations that are either

public or private, local or regional.

Evidence of applicant’s ability to solicit

and secure programmatic collaboration,

and financial and technical support

from such organizations.

d. Demonstration of support from

non-applicant participating agencies,

institutions, organizations, laboratories,

individuals, consultants, etc.,

mentioned in the operational plan.

Applicant should provide (in an

appendix) letters of support which

clearly indicate each collaborator’s

willingness to participate in studies and

other activities with the Prevention

Epicenter. The letters should clearly

define the roles of these collaborations.

e. Demonstration of applicant’s ability

to participate in multicenter research

and demonstration studies.

4. Operational Plan (45 points)

a. The extent to which the applicant’s

plan for establishing, operating, and

maintaining the Prevention Epicenter

clearly describes the proposed activities

and clearly identifies the roles and

responsibilities of all participating

individuals, agencies, organizations,

and institutions.

b. The extent to which the applicant

describes plans for collaboration with

other PE program sites in the

establishment and operation of the PE

program and individual Prevention

Epicenter projects, including

participation in advisory committee and

subcommittee activities, as well as

project design/development (e.g.,

protocols), management and analysis of

data, and synthesis and dissemination

of findings.

c. Description and quality of

applicant’s partnerships with necessary

and appropriate individuals,

departments, agencies and organizations

for establishing and operating the

proposed Prevention Epicenter projects.

d. Consistency of the proposed

projects with regard to Prevention

Epicenter goals.

e. Description of the operational plan

for conducting core multicenter

collaborative projects, including the

extent to which: (1) the project is

consistent with one or more of the

stated goals of the PE program, (2) the

objectives of the proposed project are

specific, measurable, and time-phased;

(3) the plan clearly describes applicant’s

technical approach/methods for

conducting the proposed project(s); and

(4) the plan is adequate to accomplish

the stated objectives.

f. Description of the operational plan

for conducting one or two investigatorinitiated projects, including the extent

to which: (1) The project is consistent

with one or more of the stated goals of

the PE program, (2) the objectives of the

proposed project are specific,

measurable, and time-phased; 3) the

plan clearly describes applicant’s

technical approach/methods for

conducting the proposed project(s); and

(4) the plan is adequate to accomplish

the stated objectives.

g. Identification of applicant’s key

professional personnel to be assigned to

the Prevention Epicenter and to specific

33552 Federal Register / Vol. 65, No. 101 / Wednesday, May 24, 2000 / Notices

projects as well as key professional

personnel from other participating or

collaborating institutions, agencies,

organizations outside of the applicant’s

agency that will be assigned to PE

activities (provide curriculum vitae for

each in an appendix). Clear

identification of applicants’ respective

roles in the management and operation

of the Prevention Epicenter and in

individual projects. Descriptions of

participants’ experience in conducting

work similar to that proposed in this

announcement.

h. Description of all support staff and

services to be assigned to the Prevention

Epicenter.

i. The degree to which the applicant

has met the CDC Policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed research. This includes (a) the

proposed plan for the inclusion of both

sexes and racial and ethnic minority

populations for appropriate

representation, (b) the proposed

justification when representation is

limited or absent, (c) a statement as to

whether the design of the study is

adequate to measure differences when

warranted and (d) a statement as to

whether the plans for recruitment and

outreach for study participants include

the process of establishing partnerships

with community(ies) and recognition of

mutual benefits.

5. Evaluation (5 points)

a. Quality of plan for monitoring and

evaluating scientific and operational

accomplishments of the Prevention

Epicenter and of individual Center

projects.

b. Quality of plan for monitoring and

evaluating progress in achieving the

purpose and overall goals of this

cooperative agreement program.

6. Budget (not scored)

Extent to which the line-item budget

is detailed, clearly justified, and

consistent with the purpose and

objectives of this program.

7. Human Subjects (not scored)

Does the application adequately

address the requirements of Title 45

CFR part 46 for the protection of human

subjects?

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of

1. progress reports (semiannual);

2. financial status report, no more

than 90 days after the end of the budget

period; and

3. final financial status and

performance reports, no more than 90

days after the end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where To Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I in the

application kit.

AR–1 Human Subjects Requirements

AR–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–7 Executive Order 12372 Review

AR–9 Paperwork Reduction Act

Requirements

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–15 Proof of Non-Profit Status

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

section 301(a) and 317(k)(2) of the

Public Health Service Act, [42 U.S.C.

sections 241(a) and 247b(k)(2)], as

amended. The Catalog of Federal

Domestic Assistance number is 93.283.

J. Where to Obtain Additional

Information

For this and other CDC

announcements, please see the CDC

home page on the Internet: http://

www.cdc.gov (click on ‘‘Funding’’). To

receive additional written information

and to request an application kit, call 1–

888-GRANTS4 (1–888 472–6874). You

will be asked to leave your name and

address and will be instructed to

identify the Announcement number of

interest.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from: Gladys

Gissentanna, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Room 3000,

Atlanta, GA 30341–4146, Telephone

number 770–488–2753, Email address

gcg4@cdc.gov

For program technical assistance,

contact: Steve Solomon, M.D., Hospital

Infections Program, National Center for

Infectious Diseases, Centers for Disease

Control and Prevention, 1600 Clifton

Road, N.E. Mailstop A–07, Atlanta, GA

30333, Telephone number 404–639–

6476, Email address sls1@cdc.gov

Dated: May 18, 2000.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 00–13028 Filed 5–23–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00093]

States Helping States Through The

Association of Food And Drug

Officials; Notice of Availability of

Funds

A. Purpose

The Centers for Disease Control and

Prevention, (CDC) announces the

availability of fiscal year (FY) 2000

funds for a cooperative agreement

program for States Helping States

Through the Association of Food and

Drug Officials.

B. Eligible Applicant

Assistance will be provided only to

the Association of Food and Drug

Officials (AFDO). No other applications

are solicited.

AFDO is the only organization

qualified to conduct this work because:

1. AFDO is the only organization that

represents the state and local food

protection regulatory agencies. Regular

members are official heads of State or

local regulatory agencies or personnel

under their supervision. The

Association’s principle purpose is to act

as a leader and resource to state and

local regulatory agencies in developing

strategies to resolve and promote public

health and consumer protection related

to the regulation of foods as well as

drugs, medical devices and consumer

products.

2. AFDO focuses on the

administration of the nation’s food

safety component of public health

programs. AFDO has unique perspective

on the infrastructure, capacity, strengths

and needs of state and local food safety

programs.

3. AFDO has experience in carrying

out national training efforts that focus

on the needs of state and local

regulatory agencies.

C. Availability of Funds

Approximately $102,000 is available

in FY 2000 to fund this Cooperative

Agreement. It is expected that the award

will begin on or about September 1,

2000, and will be made for a 12-month